Skip to main content
. 2020 Dec 21;23(7):1160–1167. doi: 10.1093/ntr/ntaa267

Table 2.

Two-Week Exposure to IQOS Aerosols or CS Augments Inflammatory Cytokine/Chemokine Profile in the Bronchoalveolar Fluid

Cytokine/ chemokine (pg/mL) Air IQOS CS
IL-2 1.19 ± 0.14 2.79 ± 0.28*** 2.32 ± 0.21**
IFN-γ 24.60 ± 4.94 72.53 ± 12.02** 54.92 ± 9.14
TNF-α 32.87 ± 18.50 157.94 ± 32.64* 147.15 ± 31.13*
IL-6 0.67 ± 0.09 0.92 ± 0.088 1.06 ± 0.11*
IL-9 26.50 ± 4.10 133.35 ± 14.18**** 136.36 ± 15.42****
IL-13 21.50 ± 3.76 43.62 ± 2.75*** 27.91 ± 2.39**
IL-5 1.48 ± 0.25 3.84 ± 0.37*** 2.74 ± 0.14*
IL-17A 4.22 ± 1.29 8.94 ± 1.68 6.98 ± 1.60
G-CSF 9.25 ± 1.94 8.71 ± 0.99 15.92 ± 1.91*  ,†
RANTES 13.39 ± 2.79 44.31 ± 6.12* 30.12 ± 3.62*
KC 83.29 ± 14.54 352.6 ± 53.11*** 284.27 ± 29.75*
Eotaxin 83.38 ± 19.77 386.81 ± 62.90*** 257.45 ± 28.22*
MIP-1α 11.16 ± 1.82 18.61 ± 3.04 32.27 ± 5.11**  ,†
MIP-1β 17.51 ± 5.52 121.08 ± 31.55* 141.13 ± 33.29*

Levels of various inflammation-associated cytokines and chemokines in the bronchoalveolar of mice after 2 wk of exposure to air, IQOS aerosols, or CS were quantified by Bio-Plex Pro Mouse Cytokine 23-plex Assay (Bio-Rad USA; Cat # M60009RDPD) as described in Materials and Methods. Data are mean ± SE. In each experiment, n = 10 mice were used.

*p ≤ .05, **p ≤ .01, ***p ≤ .001, ****p ≤ .0001, IQOS and CS versus air, or p ≤ .05, IQOS versus CS. Ordinary one-way ANOVA with Tukey’s post-test comparisons by GraphPad Prism 8 software (GraphPad, La Jolla, CA).